{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:59:22Z","timestamp":1791172762340,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002745","name":"Bayerische Forschungsstiftung","doi-asserted-by":"crossref","award":["AZ-872-09"],"award-info":[{"award-number":["AZ-872-09"]}],"id":[{"id":"10.13039\/501100002745","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"crossref","award":["2011.085.1"],"award-info":[{"award-number":["2011.085.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["MA 1289\/7-1"],"award-info":[{"award-number":["MA 1289\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.antiviral.2013.10.003","type":"journal-article","created":{"date-parts":[[2013,10,20]],"date-time":"2013-10-20T01:31:28Z","timestamp":1382232688000},"page":"640-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis"],"prefix":"10.1016","volume":"100","author":[{"given":"Manfred","family":"Marschall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kosulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bootz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dobner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Herz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Leban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Vitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stamminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Hutterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.10.003_b0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/187152609787847758","article-title":"Drug targets in cytomegalovirus infection","volume":"9","author":"Andrei","year":"2009","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.antiviral.2013.10.003_b0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/TP.0b013e3181e94106","article-title":"Utility of leflunomide in the treatment of complex cytomegalovirus syndromes","volume":"90","author":"Avery","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2013.10.003_b0020","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1099\/vir.0.022293-0","article-title":"Modification of the major tegument protein pp65 of 1 human cytomegalovirus inhibits viral growth and leads to the enhancement of a protein complex with pUL69 and pUL97 in infected cells","volume":"91","author":"Becke","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.10.003_b0030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/ard.59.11.841","article-title":"Leflunomide: mode of action in the treatment of rheumatoid arthritis","volume":"59","author":"Breedveld","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.antiviral.2013.10.003_b0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1399-3062.2011.00682.x","article-title":"Leflunomide for cytomegalovirus: bench to bedside","volume":"14","author":"Chacko","year":"2012","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.10.003_b0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.antiviral.2011.07.018","article-title":"The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants","volume":"92","author":"Chou","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.10.003_b0045","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/bi952168g","article-title":"The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase","volume":"35","author":"Davis","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2013.10.003_b0050","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0149-2918(00)86732-6","article-title":"Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis","volume":"21","author":"Goldenberg","year":"1999","journal-title":"Clin. Ther."},{"key":"10.1016\/j.antiviral.2013.10.003_b0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jcv.2012.02.026","article-title":"Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man","volume":"54","author":"Henao-Mart\u00ednez","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.10.003_b0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0162-3109(00)00191-0","article-title":"Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases","volume":"47","author":"Herrmann","year":"2000","journal-title":"Immunopharm"},{"key":"10.1016\/j.antiviral.2013.10.003_b0065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1517\/17425255.2.3.471","article-title":"4SCan\/vADME: intelligent library screening as a shortcut from hits to lead compounds","volume":"2","author":"Herz","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.antiviral.2013.10.003_b0075","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1152095","article-title":"Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function","volume":"320","author":"Hume","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.10.003_b0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.antiviral.2013.04.017","article-title":"Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK","volume":"99","author":"Hutterer","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.10.003_b0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/138945007779315524","article-title":"Targeting purine and pyrimidine metabolism in human apicomplexan parasites","volume":"8","author":"Hyde","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.antiviral.2013.10.003_b0090","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/01.TP.0000122185.64004.89","article-title":"Leflunomide therapy for cytomegalovirus disease in renal allograft recepients","volume":"77","author":"John","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2013.10.003_b0095","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1128\/JVI.00728-09","article-title":"A 49-kilodalton isoform of the adenovirus type 5 early region 1B 55-kilodalton protein is sufficient to support virus replication","volume":"83","author":"Kindsm\u00fcller","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.003_b0100","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2007-06-095414","article-title":"Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells","volume":"110","author":"Klenovsek","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2013.10.003_b0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bmcl.2005.10.011","article-title":"Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors","volume":"15","author":"Leban","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2013.10.003_b0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.coph.2008.07.002","article-title":"Antiviral strategies to combat cytomegalovirus infections in transplant recipients","volume":"8","author":"Lischka","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.antiviral.2013.10.003_b0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0969-2126(00)00077-0","article-title":"Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents","volume":"8","author":"Liu","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2013.10.003_b0125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/fmb.09.40","article-title":"Molecular targets for antiviral therapy of cytomegalovirus infections","volume":"4","author":"Marschall","year":"2009","journal-title":"Future Microbiol."},{"key":"10.1016\/j.antiviral.2013.10.003_b0130","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.44.6.1588-1597.2000","article-title":"Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents","volume":"44","author":"Marschall","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.10.003_b0135","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/AAC.05908-11","article-title":"In vitro evaluation of the activities of the novel anti-cytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses","volume":"56","author":"Marschall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.10.003_b0140","series-title":"Fields Virology","first-page":"2701","article-title":"Cytomegaloviruses","author":"Mocarski","year":"2007"},{"key":"10.1016\/j.antiviral.2013.10.003_b0235","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1021\/jm301848w","article-title":"On dihydroorotate dehydrogenases and their inhibitors and uses","volume":"56","author":"Munier-Lehmann","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.10.003_b0145","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra032906","article-title":"New drugs for rheumatoid arthritis","volume":"350","author":"Olsen","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.10.003_b0240","first-page":"4644","article-title":"In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients","volume":"50","author":"Peters","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2013.10.003_b0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/187152610791163336","article-title":"Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy","volume":"10","author":"Phillips","year":"2010","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.antiviral.2013.10.003_b0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/187152009787047752","article-title":"Tyrosine kinase blockers: new hope for successful cancer therapy","volume":"9","author":"Pytel","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.antiviral.2013.10.003_b0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.antiviral.2006.06.004","article-title":"Antiviral activity of Arthrospira-derived spirulan-like substances","volume":"72","author":"Rechter","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.10.003_b0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2006.03.004","article-title":"Antiviral drug resistance","volume":"71","author":"Richman","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.10.003_b0170","doi-asserted-by":"crossref","first-page":"21682","DOI":"10.1074\/jbc.273.34.21682","article-title":"Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans","volume":"273","author":"R\u00fcckemann","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.10.003_b0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2008.01.154","article-title":"Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo","volume":"79","author":"Schleiss","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.10.003_b0185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00894-004-0201-1","article-title":"ProPose: a docking engine based on a fully configurable protein\u2013ligand interaction model","volume":"10","author":"Seifert","year":"2004","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.antiviral.2013.10.003_b0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/157489107779561634","article-title":"Novel therapies for cytomegalovirus disease","volume":"2","author":"Steininger","year":"2007","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"key":"10.1016\/j.antiviral.2013.10.003_b0195","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1016\/j.bmcl.2007.09.016","article-title":"Discovery of 5-HT6 receptor ligands based on virtual HTS","volume":"17","author":"Tasler","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2013.10.003_b0200","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.bmcl.2009.01.054","article-title":"N-substituted 2\u2032-(aminoaryl)benzothiazoles as kinase inhibitors: hit identification and scaffold hopping","volume":"19","author":"Tasler","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2013.10.003_b0205","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1099\/vir.0.005827-0","article-title":"Cytomegaloviral protein kinase pUL97 interacts with the nuclear mRNA export factor pUL69 to modulate its intranuclear localization and activity","volume":"90","author":"Thomas","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.10.003_b0210","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2174\/138955711797247707","article-title":"Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors","volume":"11","author":"Vyas","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.10.003_b0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000053979","article-title":"Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide","volume":"42","author":"Waldman","year":"1999","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2013.10.003_b0220","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00007890-199909270-00014","article-title":"Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide","volume":"68","author":"Waldman","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2013.10.003_b0225","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1128\/JVI.02510-10","article-title":"Inhibition of dengue virus through suppression of host pyrimidine biosynthesis","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.10.003_b0230","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1099\/vir.0.026799-0","article-title":"Two isoforms of the protein kinase pUL97 of human cytomegalovirus are differentially regulated in their nuclear translocation","volume":"92","author":"Webel","year":"2011","journal-title":"J. Gen. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:53:08Z","timestamp":1539305588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213002933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0166354213002933"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.10.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}